Enhanced neutralization of feline immunodeficiency virus by complement viral lysis.
The ability of complement to inactivate feline immunodeficiency virus (FIV) was examined. Treatment of virus with complement plus sub-neutralizing titers of antiserum resulted in a significant reduction in the virus titer compared with treatment of the virus with complement or antibody alone. One of the mechanisms by which cat complement inactivates FIV was shown to be by viral lysis as determined by a reverse transcriptase release assay. Kinetic studies revealed that viral lysis is initiated soon after the addition of complement to a mixture of virus and antiserum. Treatment of FIV with normal non-complement-inactivated human serum resulted in virus inactivation and release of viral RT in the absence of specific antiserum. It appears that FIV activates complement directly through the classical pathway and that integrity of the membrane attack components is a requirement for FIV lysis by human serum. The vulnerability of two distinct isolates of FIV to complement lysis was compared using complement from different species. Oradell isolate was more sensitive to complement lysis than the Petaluma isolate as assessed by reverse transcriptase release. It appears that factors intrinsic to the virus isolate may influence the amplitude of complement-dependent viral lysis.
Fevereiro
M
M
Department of Veterinary Microbiology, Immunology and Parasitology, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853.
Roneker
C
C
de Noronha
F
F
D000818:Animals; D002415:Cats; D003171:Complement Pathway, Classical; D003165:Complement System Proteins / Q000276:immunology*; D016181:Feline Acquired Immunodeficiency Syndrome / Q000276:immunology; D006168:Guinea Pigs; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D016089:Immunodeficiency Virus, Feline / Q000201:enzymology / Q000276:immunology*; D007700:Kinetics; D009500:Neutralization Tests; D012194:RNA-Directed DNA Polymerase / Q000096:biosynthesis; D011817:Rabbits; D013047:Specific Pathogen-Free Organisms; D014158:Transcription, Genetic
D007106:Immune Sera; D003165:Complement System Proteins; D012194:RNA-Directed DNA Polymerase